Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome

Clinical trial NCT00004208 · COMPLETED

Trial details

NCT number: NCT00004208
Sponsor: Swiss Cancer Institute
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2000-08-01
Primary completion: 2006-10-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.